Table 4
Level 2 DDIs with Disparate Compliance Rates
| Drug Pair | Non-Tiered | Tiered |
| Cyclosporine & Verapamil | 0.0% | 60.0% |
| Indomethacin & Ketorolac Tromethamine | 0.0% | 59.5% |
| Theophylline Immediate Release & Levofloxacin | 0.0% | 55.6% |
| Magnesium Hydroxide & Minocycline | 10.0% | 70.0% |
| Heparin & Drotrecogin Alfa | 11.8% | 50.0% |
| Ciprofloxacin & Sucralfate | 12.5% | 50.0% |
| Ketorolac Tromethamine & Celecoxib | 15.0% | 66.7% |
| Magnesium Hydroxide & Tetracycline | 15.4% | 76.9% |
| Sertraline & Linezolid | 16.7% | 52.6% |
| Theophylline & Levofloxacin | 16.7% | 50.0% |
| Cyclobenzaprine & Tramadol | 17.6% | 53.8% |
| Citalopram & Linezolid | 21.7% | 76.9% |
| Heparin & Enoxaparin | 22.1% | 70.4% |
| Fluoxetine & Epinephrine Continuous Infusion | 25.0% | 55.0% |
| Acetylsalicylic Acid & Drotrecogin Alfa | 33.3% | 60.0% |
-
DDI = drug–drug interaction.
